Search results
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 15 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued ...
Johnson & Johnson's Bankruptcy Tactics Are Fraudulent, Plaintiffs Accuse Company Of Defrauding...
Benzinga· 1 day agoA group of cancer victims has reportedly filed a lawsuit againstJohnson & Johnson JNJ, accusing the...
Norges Bank Purchases New Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoJohnson & Johnson comprises 0.7% of Norges Bank’s investment portfolio, making the stock its 18th largest position. Other hedge funds and other institutional ...
Johnson to Invite Netanyahu to Capitol Hill
The American Conservative· 2 hours agoHouse Speaker Mike Johnson announced Thursday that Israeli Prime Minister Benjamin Netanyahu will address Congress. In a speech commemorating Israel’s...
Summit X LLC Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoSummit X LLC lessened its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.3% during the 4th quarter, according to the company in its ...
Cornerstone Advisors LLC Sells 7,098 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoCornerstone Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.8% in the 4th quarter, according to its most ...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock |...
The Motley Fool· 3 days agoJohnson & Johnson (JNJ -0.02%) is dividend royalty. The healthcare behemoth has increased its...
Robeco Institutional Asset Management B.V. Sells 501,987 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoRobeco Institutional Asset Management B.V. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 41.0% during the fourth quarter, according ...
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies By Reuters
Investing.com· 2 days agoA group of cancer victims sued Johnson & Johnson (NYSE:JNJ) on Wednesday, accusing the healthcare...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 4 hours agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...